We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.
- Authors
Kopetz, Scott; Chang, George J; Overman, Michael J; Eng, Cathy; Sargent, Daniel J; Larson, David W; Grothey, Axel; Vauthey, Jean-Nicolas; Nagorney, David M; McWilliams, Robert R
- Abstract
Fluorouracil/leucovorin as the sole therapy for metastatic colorectal cancer (CRC) provides an overall survival of 8 to 12 months. With an increase in surgical resections of metastatic disease and development of new chemotherapies, indirect evidence suggests that outcomes for patients are improving in the general population, although the incremental gain has not yet been quantified.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 22, p3677
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.20.5278